Endocrinology, Vol 128, 174-190, Copyright © 1991 by Endocrine Society

ARTICLES

Chromogranin A: posttranslational modifications in secretory granules

JA Barbosa, BM Gill, MA Takiyyuddin and DT O'Connor
Department of Medicine, University of California, San Diego.

The primary structure of chromogranin A indicates multiple domains which might be subject to posttranslational modification. We explored chromogranin A's proteolytic cleavage, glycosylation, and possible intermolecular disulfide links, using biochemical and cell biological approaches. Anti-chromogranin A region-specific immunoblots on chromaffin granules suggested bidirectional endoproteolytic cleavage of chromogranin A; control experiments ruled out artifactual cleavage during granule isolation or lysis. Isolation of chromogranin A-derived peptides by gel filtration chromatography or sodium dodecyl sulfate- polyacrylamide gel electrophoresis (SDS-PAGE), followed by N-terminal amino acid sequencing, established several cleavage sites, including at least two at dibasic sites. Secretion of chromogranin A from bovine chromaffin cells did not initiate further cleavage, nor did prolonged exposure of secreted chromogranins to the secretory cells. The chromogranin A cleavage pattern was qualitatively similar in other neuroendocrine tissues, though cleavage was more complete in adrenal medullary than in anterior pituitary hormone storage vesicles, and N- terminal fragments of 45 and 55 kilodaltons were more prominent in the hypothalamus. A similar cleavage pattern was seen in human pheochromocytoma granules, as judged by chromogranin A region-specific immunoblots, fragment isolation by SDS-PAGE, and microsequencing. The presence of full-length chromogranin A as the core protein of a chromaffin granule soluble proteoglycan was suggested in bovine (but not human) chromaffin granules by glycoprotein staining, chondroitinase ABC digestion, chemical deglycosylation, and region-specific immunoblotting. Human (but not bovine) chromogranin A displayed intermolecular disulfide crosslinks on SDS-PAGE gels and immunoblotting. These results document diverse structural paths that the chromogranin A molecule may take in endocrine secretory cells after its translation.

This article has been cited by other articles:

				T. A. Greenwood, F. Rao, M. Stridsberg, N. R. Mahapatra, M. Mahata, E. O. Lillie, S. K. Mahata, L. Taupenot, N. J. Schork, and D. T. O'Connor Pleiotropic effects of novel trans-acting loci influencing human sympathochromaffin secretion Physiol Genomics, May 16, 2006; 25(3): 470 - 479. [Abstract] [Full Text] [PDF]

				J. R. Peinado, R. Vazquez-Martinez, D. Cruz-Garcia, A. Ruiz-Navarro, Y. Anouar, M. C. Tonon, H. Vaudry, F. Gracia-Navarro, J. P. Castano, and M. M. Malagon Differential Expression and Processing of Chromogranin A and Secretogranin II in Relation to the Secretory Status of Endocrine Cells Endocrinology, March 1, 2006; 147(3): 1408 - 1418. [Abstract] [Full Text] [PDF]

				D. T. O'Connor, P. E. Cadman, C. Smiley, R. M. Salem, F. Rao, J. Smith, S. D. Funk, S. K. Mahata, M. Mahata, G. Wen, et al. Pancreastatin: Multiple Actions on Human Intermediary Metabolism in Vivo, Variation in Disease, and Naturally Occurring Functional Genetic Polymorphism J. Clin. Endocrinol. Metab., September 1, 2005; 90(9): 5414 - 5425. [Abstract] [Full Text] [PDF]

				M. d'Herbomez, V. Gouze, D. Huglo, M. Nocaudie, F. Pattou, C. Proye, J.-L. Wemeau, and X. Marchandise Chromogranin A Assay and 131I-MIBG Scintigraphy for Diagnosis and Follow-Up of Pheochromocytoma J. Nucl. Med., July 1, 2001; 42(7): 993 - 997. [Abstract] [Full Text] [PDF]

				P. Norlén, W. J. Curry, M. Björkqvist, A. Maule, R. T. Cunningham, R. B. Hogg, P. Harriott, C. F. Johnston, J. C. Hutton, and R. Håkanson Cell-specific Processing of Chromogranin A in Endocrine Cells of the Rat Stomach J. Histochem. Cytochem., January 1, 2001; 49(1): 9 - 18. [Abstract] [Full Text]

				J. Jongsma, M. H. Oomen, M. A. Noordzij, W. M. Van Weerden, G. J. M. Martens, T. H. van der Kwast, F. H. Schröder, and G. J. van Steenbrugge Androgen Deprivation of the Prohormone Convertase-310 Human Prostate Cancer Model System Induces Neuroendocrine Differentiation Cancer Res., February 1, 2000; 60(3): 741 - 748. [Abstract] [Full Text]

				P. Gadroy, M. Stridsberg, C. Capon, J.-C. Michalski, J.-M. Strub, A. Van Dorsselaer, D. Aunis, and M.-H. Metz-Boutigue Phosphorylation and O-Glycosylation Sites of Human Chromogranin A (CGA79-439) from Urine of Patients with Carcinoid Tumors J. Biol. Chem., December 18, 1998; 273(51): 34087 - 34097. [Abstract] [Full Text] [PDF]

				J.-M. Strub, O. Sorokine, A. Van Dorsselaer, D. Aunis, and M.-H. Metz-Boutigue Phosphorylation and O-Glycosylation Sites of Bovine Chromogranin A from Adrenal Medullary Chromaffin Granules and Their Relationship with Biological Activities J. Biol. Chem., May 2, 1997; 272(18): 11928 - 11936. [Abstract] [Full Text] [PDF]

				K. Tang, H. Wu, S. K. Mahata, L. Taupenot, D. J. Rozansky, R. J. Parmer, and D. T. O'Connor Stimulus-transcription Coupling in Pheochromocytoma Cells. PROMOTER REGION-SPECIFIC ACTIVATION OF CHROMOGRANIN A BIOSYNTHESIS J. Biol. Chem., November 8, 1996; 271(45): 28382 - 28390. [Abstract] [Full Text] [PDF]

				M. A. Takiyyuddin, R. J. Parmer, M. T. Kailasam, J. H. Cervenka, B. Kennedy, M. G. Ziegler, M.-C. Lin, J. Li, C. E. Grim, F. A. Wright, et al. Chromogranin A in Human Hypertension : Influence of Heredity Hypertension, July 1, 1995; 26(1): 213 - 220. [Abstract] [Full Text]

				C. V. Taylor, L. Taupenot, S. K. Mahata, M. Mahata, H. Wu, S. Yasothornsrikul, T. Toneff, C. Caporale, Q. Jiang, R. J. Parmer, et al. Formation of the Catecholamine Release-inhibitory Peptide Catestatin from Chromogranin A. DETERMINATION OF PROTEOLYTIC CLEAVAGE SITES IN HORMONE STORAGE GRANULES J. Biol. Chem., July 21, 2000; 275(30): 22905 - 22915. [Abstract] [Full Text] [PDF]